Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4E family member 2 pseudogene 1 (EIF4E2P1) is a processed pseudogene derived from the protein-coding gene EIF4E2, which encodes a member of the eukaryotic translation initiation factor 4E (eIF4E) family[1][7]. EIF4E2P1 is a non-coding DNA segment that closely resembles the functional EIF4E2 gene but does not produce a functional protein product. It is classified as a retrocopy—a genomic segment formed by reverse transcription of mRNA and insertion into a new genomic location. While some pseudogenes can occasionally acquire regulatory functions or serve as molecular decoys, no protein product or functional role has been established for EIF4E2P1. Consequently, it is not considered a therapeutic target, receptor, enzyme, or involved in any major biological or disease processes at this time[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4E family member 2 pseudogene 1 (EIF4E2P1).